Home › Funds › Centiva Capital, LP › TECH

Centiva Capital, LP position in TECH

BIO-TECHNE CORP · Health Care

Centiva Capital, LP reported holding 115,829 shares of TECH (BIO-TECHNE CORP) in its Q3 2026 13F filing — a position valued at US$8.4M, representing 0.40% of its reported portfolio and ranking #43 among its reported holdings. Centiva Capital, LP has disclosed TECH holdings in 7 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)115.83K sh
Reported value held$8.39M
Portfolio Weight0.40%
First reportedQ3 2023
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Centiva Capital, LP's TECH position evolved

Centiva Capital, LP first disclosed a stake in TECH in Q3 2023 at 3,640 shares (US$248K). The position peaked in Q2 2026 at 225,000 shares, worth US$15.9M. Across 7 filings, Centiva Capital, LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 115,829 shares valued at US$8.4M — a reduction of -109,171 shares quarter over quarter.. Notable position changes include a 149% increase in Q2 2024 (shares rose 12% over the following quarter), a 36% trim in Q2 2025 (shares rose 8% over the following quarter), a 49% trim in Q3 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.64K $247.78K New
Q1 2024 10.65K $749.72K New
Q2 2024 26.51K $1.90M Add
Q1 2025 15.45K $905.66K New
Q2 2025 9.84K $506.32K Reduce
Q2 2026 225.00K $15.90M New
Q3 2026 115.83K $8.39M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TECH and 13F data

TECH (BIO-TECHNE CORP) is a Health Care company. 25 other funds we track also report a position in TECH — the largest reported positions include HBK INVESTMENTS L P (US$482.2M), Ruane Cunniff & Goldfarb (Sequoia) (US$236.6M), SNYDER CAPITAL MANAGEMENT L P (US$223.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TECH

All TECH fund holders →

FAQ

How long has Centiva Capital, LP held TECH?

Centiva Capital, LP has disclosed TECH holdings in 7 of the last 13 reported quarters, going back to Q3 2023.

What is Centiva Capital, LP's current position in TECH?

As of Q3 2026, Centiva Capital, LP holds 115.83K shares of TECH (BIO-TECHNE CORP), valued at $8.39M, representing 0.40% of its reported portfolio and ranking #43.

Has Centiva Capital, LP been buying or selling TECH?

In the latest 13F filing (Q3 2026), Centiva Capital, LP reduced its position in TECH. The position peaked in Q2 2026 at 225.00K shares.

Which other funds hold TECH?

Other major institutional holders of TECH include HBK INVESTMENTS L P, Ruane Cunniff & Goldfarb (Sequoia), SNYDER CAPITAL MANAGEMENT L P, among 25 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.